Clinical Trial Update: S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating zoledronic acid or ibandronate to prevent bone problems in women with stage IV breast cancer that has spread to bone has been withdrawn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Breast Cancer
• Hypercalcemia of Malignancy

Drugs mentioned

• Boniva (ibandronate)
• Zometa (Zoledronic acid)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer, Hypercalcemia of Malignancy | Phase 3 | Status: WITHDRAWN